Newsletters and more news updates

The latest newsletter (Summer 2017) can be downloaded here. Just follow the link or right click the link and save as…

The Urology Patient Experience Survey mentioned in the Spring 2016 newsletter can be found via following link: Urology Patient Experience Survey

David Casley, Prospect Publicity 07860 369064; Email  prospect.bristol@gmail.com

MORE NEWS

Isotope could be game-changer

A new brachytherapy isotope, Cesium-131, could be a game-changer, a US study indicates (Aug ’17). See

Remarkable results claimed for nuclear medicine treatment

Remarkable results are claimed for an experimental treatment in Australia for advanced prostate cancer patients who had exhausted all their options. It is a disruptive technology in the field of nuclear medicine, pioneered in Germany four years ago (Aug ’17). See

Early Abiraterone ‘improves survival’

A clinical trial funded by Cancer Research UK has revealed that offering abiraterone earlier in treatment can improve survival in men with advanced prostate cancer. The results are game-changing (Aug ’17). See

New hope for advanced patients

Scientists have developed a blood test that could pick out which men with advanced prostate cancer would benefit from a new drug treatment. The test detects cancer DNA, helping doctors check if precision drugs are working. Cancer Research UK said the test could “greatly improve survival”, but added that larger studies are needed to confirm if it is reliable. (Jun ’17). See

New treatment to be tried out

After a pilot study, an associate Australian professor is to lead a trial of 200 patients with nuclear medicine treatment – what he believes could be a game-changer in the treatment of advanced prostate cancer (July ’17). See

Ignorance over newer tests

Half of urologists are unaware of newer, more sensitive biomarker tests for detecting prostate cancer, according to a worldwide survey of 300 mainly European specialists. The new tests reduce the need for biopsies (July ’17). See

Defeating therapy resistance

A new US study sheds light on a signalling circuit in cells that drives therapy resistance in prostate cancer. Targeting the components of this circuit suppresses advanced cancer development. See.

Laser treatment success

Surgeons described a new treatment for early stage prostate cancer as “truly transformative”. The approach, tested in Europe, uses lasers and a drug made from deep-sea bacteria to eliminate tumours, but without causing severe side effects. See.

Testosterone finding

Drastically altering the levels of testosterone could cause cancer cells to die even after they become hormone-resistant, according to new research unveiled in December. See.


Treatment breakthrough

After a bombardment of evidence from Prostate Cancer UK, NICE announced in November ’16 they will undertake an exceptional review of this cancer’s clinical guidelines. It will mean lifesaving new diagnosis and treatment sooner than expected. See.

PSA test row

The use of PSA testing may be unnecessary, the Academy of Medical Royal Colleges reported in October ’16. But Prostate Cancer UK made clear the test is still the best first step for diagnosis until a more robust one suitable for a screening programme is devised. Several Prospect members wrote to the BBC or their MP about the situation. See. And crowdfunding donations were successfully sought for a new non-invasive and affordable diagnostic test for the early detection of this cancer. See.

World first hailed

Scientists in Belfast claim a major breakthrough in prostate cancer treatment. It is hoped the new discovery, hailed a world first, could help stop the spread of the disease and prevent relapses. Researchers have found that combining hormone therapy with a new drug, OCT1002, can improve treatment effectiveness. See.

Drug targets tumours

A radioactive drug, which behaves like the substance used to kill Russian ex-spy Alexander Litvinenko, could be used to treat prostate cancer patients. It targets tumours that have spread to the bones and has been approved by NICE. See.

Early detection claimed

Scientists at Israel’s Weizmann Institute might have found a prostate cancer cure, at least if it’s caught early. See.

Urine test created

Scientists have created a urine test for prostate cancer after trials on 155 men in Bristol. See

New diagnosis tool; Zytiga affordable

A new risk assessment tool for GPs is set to revolutionise prostate cancer diagnosis. See. And NICE has agreed that abiraterone (Zytiga) is affordable after a lower price was agreed with the makers. See.

Southmead charity appeal’s events

See Southmead Hospital Charity’s fundraising events here and you can make a payment.

More accurate predictions?

Patients might be offered a more accurate prediction of their prostate cancer risk with a novel method developed by Cambridge University researchers. See

Biopsies may be ‘out’

Urologists are committed to rolling out diagnostic use of the new MRI scans once their benefits are officially confirmed. The scans make it possible to rule out the need for a biopsy in many men who don’t have a clinically significant prostate cancer. See. Latest on this here. And US researchers have identified a marker of aggressive prostate cancer. See

Tumour mapped

In a world first, Australian researchers have mapped the entire genome of a prostate tumour (April 2017). See

Improved PSA test in view

Birmingham researchers are working on an improved PSA test. See. And in April 2016 Tackle reached agreement on the best way to use the PSA test. The guidance, developed with and for GPs and practice nurses, is on better use of the test in men without symptoms. See

Cancer ‘breakthrough’

A new treatment which trains the immune system to attack “liquid” blood cancers cancer has shown “extraordinary” results and could be a potential breakthrough in curing the disease. It is hoped to progress to patients with solid tumours, but this will be challenging and some of those treated suffered severe side effects. See